Nasivin Soft (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride is a nasal decongestant that acts on the vascular structures of the nasal mucosa to reduce swelling and improve airflow.

• Common cold: alleviates nasal blockage and improves breathing.
• Sinusitis: reduces mucosal edema, facilitating sinus drainage.
• Allergic rhinitis: diminishes congestion caused by allergen‑induced inflammation.

• Oxymetazoline Hydrochloride selectively stimulates alpha‑adrenergic receptors on the smooth muscle of nasal mucosal blood vessels. This activation causes vasoconstriction, leading to reduced blood flow, decreased edema, and consequently less nasal congestion, allowing improved airflow through the nasal passages.

Oxymetazoline Hydrochloride may cause several adverse reactions, most of which are mild and transient.

Common Side Effects

• Nasal irritation or burning sensation.
• Dryness of the nasal mucosa.
• Sneezing.
• Headache.
• Bitter or metallic taste.
• Minor nosebleeds (epistaxis).

Serious or Rare Side Effects

• Rebound nasal congestion (rhinitis medicamentosa) with prolonged use.
• Elevated blood pressure or hypertension.
• Rapid heart rate (tachycardia) or arrhythmias.
• Severe allergic reactions such as anaphylaxis.
• Persistent nasal ulceration.
• Visual disturbances (rare).

Before using Oxymetazoline Hydrochloride nasal spray, consider the following safety measures.

• Use duration: limit use to no more than three consecutive days to avoid rebound congestion.
• Cardiovascular conditions: avoid if you have uncontrolled hypertension or heart disease.
• Pregnancy and lactation: consult a healthcare professional before use.
• Children: use only as directed by a pediatrician; not recommended for infants under six months.
• Drug interactions: discuss all current medications with your prescriber.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline Hydrochloride can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): may cause hypertensive crisis.
• Sympathomimetic agents (e.g., pseudoephedrine): increased risk of cardiovascular side effects.
• Tricyclic antidepressants: potential for additive pressor effects.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may blunt tachycardia but still require monitoring.
• Antihypertensive drugs: possible reduction in blood‑pressure‑lowering effect.
• Other nasal decongestants: risk of excessive vasoconstriction and rebound congestion.